SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 70 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.17 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $8,237,142 | +25.1% | 8,580,357 | -2.2% | 0.00% | – |
| Q1 2023 | $6,583,252 | +112.7% | 8,777,670 | +4.5% | 0.00% | – |
| Q4 2022 | $3,095,506 | -16.9% | 8,400,287 | -3.1% | 0.00% | – |
| Q3 2022 | $3,727,000 | -45.9% | 8,667,120 | -1.8% | 0.00% | – |
| Q2 2022 | $6,886,000 | -33.0% | 8,828,676 | +10.9% | 0.00% | – |
| Q1 2022 | $10,273,000 | -14.8% | 7,963,782 | -16.1% | 0.00% | – |
| Q4 2021 | $12,055,000 | -48.4% | 9,492,321 | -11.5% | 0.00% | -100.0% |
| Q3 2021 | $23,373,000 | -53.3% | 10,721,177 | -19.7% | 0.00% | 0.0% |
| Q2 2021 | $50,041,000 | +21.6% | 13,344,285 | +5.7% | 0.00% | 0.0% |
| Q1 2021 | $41,161,000 | -0.2% | 12,626,136 | +4.4% | 0.00% | 0.0% |
| Q4 2020 | $41,256,000 | -12.0% | 12,098,371 | +5.2% | 0.00% | -50.0% |
| Q3 2020 | $46,907,000 | +14.5% | 11,496,751 | -5.2% | 0.00% | +100.0% |
| Q2 2020 | $40,970,000 | +32.5% | 12,121,314 | -8.6% | 0.00% | 0.0% |
| Q1 2020 | $30,916,000 | -37.3% | 13,268,542 | -2.1% | 0.00% | -50.0% |
| Q4 2019 | $49,345,000 | -53.5% | 13,556,091 | +6.0% | 0.00% | -50.0% |
| Q3 2019 | $106,081,000 | +2.9% | 12,788,491 | +6.8% | 0.00% | 0.0% |
| Q2 2019 | $103,085,000 | -15.4% | 11,972,641 | +5.1% | 0.00% | -20.0% |
| Q1 2019 | $121,792,000 | +25.3% | 11,393,141 | +2.5% | 0.01% | +25.0% |
| Q4 2018 | $97,229,000 | -47.0% | 11,112,007 | +1.9% | 0.00% | -42.9% |
| Q3 2018 | $183,289,000 | -14.9% | 10,910,048 | +6.2% | 0.01% | -22.2% |
| Q2 2018 | $215,279,000 | +56.2% | 10,270,973 | +19.9% | 0.01% | +50.0% |
| Q1 2018 | $137,843,000 | -8.3% | 8,566,984 | +8.0% | 0.01% | -14.3% |
| Q4 2017 | $150,315,000 | +52.6% | 7,932,194 | +13.3% | 0.01% | +40.0% |
| Q3 2017 | $98,481,000 | +81.3% | 6,999,414 | -4.0% | 0.01% | +66.7% |
| Q2 2017 | $54,331,000 | +15.9% | 7,292,704 | +1.2% | 0.00% | +50.0% |
| Q1 2017 | $46,858,000 | +67.0% | 7,208,723 | +13.8% | 0.00% | 0.0% |
| Q4 2016 | $28,059,000 | +2.6% | 6,333,852 | +8.2% | 0.00% | 0.0% |
| Q3 2016 | $27,341,000 | -26.0% | 5,854,667 | +4.1% | 0.00% | 0.0% |
| Q2 2016 | $36,951,000 | +11.2% | 5,624,192 | +7.6% | 0.00% | 0.0% |
| Q1 2016 | $33,235,000 | +7.6% | 5,225,473 | +2.0% | 0.00% | 0.0% |
| Q4 2015 | $30,898,000 | +11.4% | 5,124,032 | +10.4% | 0.00% | +100.0% |
| Q3 2015 | $27,748,000 | -6.1% | 4,640,250 | +7.4% | 0.00% | -50.0% |
| Q2 2015 | $29,563,000 | +18.5% | 4,322,068 | +5.2% | 0.00% | 0.0% |
| Q1 2015 | $24,949,000 | -13.2% | 4,110,317 | -0.8% | 0.00% | 0.0% |
| Q4 2014 | $28,728,000 | -11.1% | 4,145,354 | +4.4% | 0.00% | -33.3% |
| Q3 2014 | $32,308,000 | +6.1% | 3,969,066 | +6.0% | 0.00% | +50.0% |
| Q2 2014 | $30,453,000 | +4.6% | 3,745,639 | +0.9% | 0.00% | 0.0% |
| Q1 2014 | $29,106,000 | -9.6% | 3,712,514 | +2.1% | 0.00% | -33.3% |
| Q4 2013 | $32,191,000 | +15.6% | 3,637,429 | +9.6% | 0.00% | 0.0% |
| Q3 2013 | $27,835,000 | +12.4% | 3,317,580 | -0.0% | 0.00% | 0.0% |
| Q2 2013 | $24,758,000 | – | 3,318,762 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 787,973 | $615,000 | 0.77% |
| CM Management, LLC | 600,000 | $468,000 | 0.50% |
| ARMISTICE CAPITAL, LLC | 17,100,000 | $13,338,000 | 0.23% |
| Sargent Investment Group, LLC | 614,600 | $479,000 | 0.15% |
| Ergoteles LLC | 744,275 | $581,000 | 0.02% |
| CAXTON ASSOCIATES LP | 107,135 | $84,000 | 0.01% |
| MCDONALD PARTNERS LLC | 42,570 | $33,000 | 0.01% |
| Sonora Investment Management Group, LLC | 103,000 | $80,000 | 0.01% |
| Pinz Capital Management, LP | 15,600 | $12,000 | 0.01% |
| Crestline Management, LP | 65,362 | $51,000 | 0.01% |